{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T02:44:35Z","timestamp":1770605075377,"version":"3.49.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.sapharm.2013.07.006","type":"journal-article","created":{"date-parts":[[2013,9,7]],"date-time":"2013-09-07T10:53:45Z","timestamp":1378551225000},"page":"576-587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Contested space in the pharmacy: Public attitudes to\u00a0pharmacy harm reduction services in the West of\u00a0Scotland"],"prefix":"10.1016","volume":"10","author":[{"given":"Wendy","family":"Gidman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross","family":"Coomber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2013.07.006_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0140-6736(11)61674-7","article-title":"Drug policy and the public good: evidence for effective interventions","volume":"379","author":"Strang","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.sapharm.2013.07.006_bib2","unstructured":"EMCDDA. Mortality Related to Problem Drug Use in Europe: Public Health Implications. http:\/\/www.emcdda.europa.eu\/publications\/selected-issues\/mortality. Cited 2013 Jul\u00a031."},{"key":"10.1016\/j.sapharm.2013.07.006_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0140-6736(11)61138-0","article-title":"Extent of illicit drug use and dependence, and their contribution to the global burden of disease","volume":"379","author":"Dergenhart","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.sapharm.2013.07.006_bib4","first-page":"a337","article-title":"Contribution of problem drug users' deaths to excess mortality in Scotland: secondary analysis of cohort study","volume":"208","author":"Bloor","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.sapharm.2013.07.006_bib5","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1360-0443.2007.01762.x","article-title":"Does prescribing for opiate addiction change after national guidelines? Methadone and buprenorphine prescribing to opiate addicts by general practitioners and hospital doctors in England 1995-2005","volume":"102","author":"Strang","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.sapharm.2013.07.006_bib6","series-title":"Injecting Drug Use","year":"2012"},{"key":"10.1016\/j.sapharm.2013.07.006_bib7","series-title":"What is Harm Reduction","year":"2012"},{"key":"10.1016\/j.sapharm.2013.07.006_bib8","series-title":"World\u00a0Drug Report","year":"2010"},{"key":"10.1016\/j.sapharm.2013.07.006_bib9","series-title":"Evidence of Drug Dependence Treatment in the Prevention of HIV Among Injecting Drug Users","author":"Farrell","year":"2005"},{"issue":"11","key":"10.1016\/j.sapharm.2013.07.006_bib10","article-title":"Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment","volume":"341","author":"Kimber","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.sapharm.2013.07.006_bib11","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2478\/v10199-011-0042-z","article-title":"Numbers and narratives. Relations between patient satisfaction, retention, outcome and program factors in outpatient substance abuse treatment","volume":"28","author":"Thylstrup","year":"2011","journal-title":"Nordic Stud Alcohol Drugs"},{"key":"10.1016\/j.sapharm.2013.07.006_bib12","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jsat.2009.01.001","article-title":"What could the program have done differently? A qualitative examination of reasons for leaving outpatient treatment","volume":"37","author":"Laudet","year":"2009","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.sapharm.2013.07.006_bib13","series-title":"Sinning and Sinned Against: The Stigmatisation of Problem Drug Users","author":"Lloyd","year":"2012"},{"key":"10.1016\/j.sapharm.2013.07.006_bib14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1477-7517-4-14","article-title":"Assessing the role of syringe dispensing machines and mobile van outlets in reaching hard-to-reach and high-risk groups of injecting drug users (IDUs): a review","volume":"4","author":"Islam","year":"2007","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.sapharm.2013.07.006_bib15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/09687630600790153","article-title":"New Zealand community pharmacist attitudes toward opioid-dependent clients","volume":"13","author":"McCormick","year":"2010","journal-title":"Drug Educ Prev Policy"},{"key":"10.1016\/j.sapharm.2013.07.006_bib16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF03403970","article-title":"Methadone use in relation to hepatitis C virus testing in British Columbia","volume":"101","author":"Buxton","year":"2010","journal-title":"Can J Public Health"},{"key":"10.1016\/j.sapharm.2013.07.006_bib17","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.drugpo.2010.09.001","article-title":"Syringe exchange in community pharmacies \u2013 the Portuguese experience","volume":"21","author":"Torre","year":"2010","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.sapharm.2013.07.006_bib18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/09595230701710852","article-title":"Dispensing opioid substitution treatment: practices, attitudes and intentions of community-based pharmacists","volume":"27","author":"Lawrinson","year":"2009","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.sapharm.2013.07.006_bib19","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/pubmed\/fdm064","article-title":"Community pharmacy harm reduction services for drug misusers: national service delivery and professional attitude development over a decade in Scotland","volume":"29","author":"Matheson","year":"2007","journal-title":"J Public Health"},{"key":"10.1016\/j.sapharm.2013.07.006_bib20","series-title":"The Road to Recovery","year":"2008"},{"key":"10.1016\/j.sapharm.2013.07.006_bib21","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1477-7517-1-6","article-title":"A comprehensive system of pharmaceutical care for drug misusers","volume":"1","author":"Roberts","year":"2004","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.sapharm.2013.07.006_bib22","series-title":"Getting Serious About Stigma: The Problem With Stigmatising Drug Users","year":"2010"},{"key":"10.1016\/j.sapharm.2013.07.006_bib23","series-title":"Scottish Social Attitudes Survey 2009: Public Attitudes to Drugs and Drug Use in Scotland","author":"Ormston","year":"2009"},{"key":"10.1016\/j.sapharm.2013.07.006_bib24","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0955-3959(03)00140-3","article-title":"Pharmacy customers' views and experiences of using pharmacies which provide needle exchange services in Aberdeen and Glasgow, Scotland","volume":"14","author":"Lawrie","year":"2003","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.sapharm.2013.07.006_bib25","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1046\/j.1360-0443.1999.94913497.x","article-title":"Attitudinal factors associated with community pharmacists' involvement in services for drug misusers","author":"Matheson","year":"1999","journal-title":"Addiction"},{"key":"10.1016\/j.sapharm.2013.07.006_bib26","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.drugpo.2007.09.002","article-title":"Injecting drug users: a stigmatised and stigmatising population","volume":"20","author":"Simmonds","year":"2009","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.sapharm.2013.07.006_bib27","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.socscimed.2009.10.033","article-title":"Socio-spatial stigmatization and the contested space of addiction treatment: remapping strategies of opposition to the disorder of drugs","volume":"70","author":"Smith","year":"2010","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.sapharm.2013.07.006_bib28","series-title":"Human Nature and the Social Order","author":"Cooley","year":"1964"},{"key":"10.1016\/j.sapharm.2013.07.006_bib29","series-title":"Stigma: Notes on the Management of Spoiled Identity","author":"Goffman","year":"1963"},{"key":"10.1016\/j.sapharm.2013.07.006_bib30","series-title":"Labeling Deviant Behavior: Its Sociological Implications","author":"Schur","year":"1971"},{"key":"10.1016\/j.sapharm.2013.07.006_bib31","series-title":"Risk Acceptability According to the Social Sciences","author":"Douglas","year":"1985"},{"key":"10.1016\/j.sapharm.2013.07.006_bib32","series-title":"Scapegoats: Transferring Blame","author":"Douglas","year":"1995"},{"key":"10.1016\/j.sapharm.2013.07.006_bib33","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0140-6736(06)68184-1","article-title":"Stigma and its public health implications","volume":"367","author":"Link","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.sapharm.2013.07.006_bib34","series-title":"The Drug Treatment Outcomes Research Study (DTORS): Baseline Report","author":"Jones","year":"1984"},{"key":"10.1016\/j.sapharm.2013.07.006_bib35","series-title":"Addiction Treatment: Science and Policy for the Twenty-first Century","article-title":"In praise of stigma","author":"Satel","year":"2007"},{"key":"10.1016\/j.sapharm.2013.07.006_bib36","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/1043986207306870","article-title":"Black criminal stereotypes and racial profiling","volume":"23","author":"Welch","year":"2007","journal-title":"J Contemp Crim Just"},{"key":"10.1016\/j.sapharm.2013.07.006_bib37","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2307\/2657267","article-title":"Racial disparities in official assessments of Juvenile offenders: attributional stereotypes as mediating mechanisms","volume":"63","author":"Bridges","year":"1996","journal-title":"Am Sociol Rev"},{"key":"10.1016\/j.sapharm.2013.07.006_bib38","series-title":"Drug, Set, and Setting: The Basis for Controlled Intoxicant Use","author":"Zinberg","year":"1984"},{"key":"10.1016\/j.sapharm.2013.07.006_bib39","series-title":"The Myth of Addiction","author":"Davies","year":"1998"},{"key":"10.1016\/j.sapharm.2013.07.006_bib40","doi-asserted-by":"crossref","first-page":"660","DOI":"10.2307\/2657432","article-title":"Labeling mental illness: the effects of received services and perceived stigma on life satisfaction","volume":"62","author":"Rosenfield","year":"1997","journal-title":"Am Sociol Rev"},{"key":"10.1016\/j.sapharm.2013.07.006_bib41","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/13548500600595053","article-title":"Health-related stigma: rethinking concepts and interventions","volume":"11","author":"Weiss","year":"2006","journal-title":"Psychol Health Med"},{"key":"10.1016\/j.sapharm.2013.07.006_bib42","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1146\/annurev.soc.27.1.363","article-title":"Conceptualizing stigma","volume":"27","author":"Bruce","year":"2001","journal-title":"Annu Rev Sociol"},{"key":"10.1016\/j.sapharm.2013.07.006_bib43","first-page":"106","article-title":"Stigmatization of people with mental illness: a follow-up study within the changing minds campaign of the Royal College of Psychiatrists","volume":"4","author":"Crisp","year":"2005","journal-title":"World Psychiatry"},{"key":"10.1016\/j.sapharm.2013.07.006_bib44","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/bmj.293.6546.543","article-title":"Findings of a national survey of the role of general practitioners in the treatment of opiate misuse: views on treatment","volume":"293","author":"Glanz","year":"1986","journal-title":"BMJ"},{"key":"10.1016\/j.sapharm.2013.07.006_bib45","series-title":"Harm Reduction National and International Perspectives","author":"Inciardi","year":"1999"},{"key":"10.1016\/j.sapharm.2013.07.006_bib46","first-page":"637","article-title":"Introducing the new Scottish contract","volume":"275","author":"Bellingham","year":"2005","journal-title":"Pharm J"},{"key":"10.1016\/j.sapharm.2013.07.006_bib47","unstructured":"Department of Health. Pharmacy in the Future \u2013 Implementing the NHS plan: A Programme for Pharmacy. http:\/\/webarchive.nationalarchives.gov.uk\/+\/www.dh.gov.uk\/en\/Publicationsandstatistics\/Publications\/PublicationsPolicyAndGuidance\/DH_4005917. Cited 2013 Jul\u00a031."},{"key":"10.1016\/j.sapharm.2013.07.006_bib48","series-title":"A Vision for Pharmacy in the\u00a0New NHS","year":"2003"},{"key":"10.1016\/j.sapharm.2013.07.006_bib49","series-title":"The Right Medicine \u2013 Pharmaceutical Care in Scotland","year":"2002"},{"key":"10.1016\/j.sapharm.2013.07.006_bib50","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1111\/j.1360-0443.2005.01230.x","article-title":"Qualitative research methods within the addictions","volume":"100","author":"Neale","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.sapharm.2013.07.006_bib51","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/1467-9566.ep11347023","article-title":"The methodology of focus groups: the importance of interactions between research participants","volume":"16","author":"Kitzinger","year":"1994","journal-title":"Sociol Health Ill"},{"key":"10.1016\/j.sapharm.2013.07.006_bib52","series-title":"The Contribution of Community Pharmacy to Improving the Public's Health: Literature Review Update 2004-7","author":"Anderson","year":"2008"},{"key":"10.1016\/j.sapharm.2013.07.006_bib53","series-title":"World\u00a0Drug Report","year":"2009"},{"key":"10.1016\/j.sapharm.2013.07.006_bib54","first-page":"64","article-title":"The aftershock of deindustrialization\u2014trends in mortality in Scotland and other parts of post-industrial Europe","volume":"20","author":"Walsh","year":"2009","journal-title":"Eur J Public Health"},{"key":"10.1016\/j.sapharm.2013.07.006_bib55","series-title":"Investigating a \u2018Glasgow Effect\u2019 Why Do Equally Deprived UK Cities Experience Different Health Outcomes?","author":"Walsh","year":"2010"},{"key":"10.1016\/j.sapharm.2013.07.006_bib56","unstructured":"Parkinson T. Community Pharmacy Use Quantitative and Qualitative Research. http:\/\/webarchive.nationalarchives.gov.uk\/+\/www.dh.gov.uk\/en\/publicationsandstatistics\/publications\/publicationspolicyandguidance\/dh_083815. Cited 2012 Jul\u00a031."},{"key":"10.1016\/j.sapharm.2013.07.006_bib57","series-title":"Focus Groups: A Practical Guide for Applied Research","author":"Krueger","year":"2000"},{"key":"10.1016\/j.sapharm.2013.07.006_bib58","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/j.1365-2702.2006.01760.x","article-title":"Literature review: considerations in undertaking focus group research with culturally and linguistically diverse groups","volume":"6","author":"Halcombe","year":"2007","journal-title":"J Clin Nurs"},{"key":"10.1016\/j.sapharm.2013.07.006_bib59","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1360-0443.2009.02774.x","article-title":"Problems experienced by community pharmacists delivering opioid substitution treatment in New South Wales and Victoria, Australia","volume":"105","author":"Winstock","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.sapharm.2013.07.006_bib60","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/001789699805700104","article-title":"Views of illicit drug users on their treatment and behaviour in Scottish community pharmacies: implications for the harm reduction strategy","volume":"57","author":"Matheson","year":"1998","journal-title":"Health Educ J"},{"key":"10.1016\/j.sapharm.2013.07.006_bib61","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/14659891.2010.513756","article-title":"Treatment experiences and needs of older drug users in Bristol, UK","volume":"17","author":"Ayres","year":"2012","journal-title":"J Subst Use"},{"key":"10.1016\/j.sapharm.2013.07.006_bib62","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.drugalcdep.2006.10.014","article-title":"Stigma, discrimination and the health of illicit drug users","volume":"88","author":"Ahern","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.sapharm.2013.07.006_bib63","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1037\/0003-066X.54.9.765","article-title":"Lessons from social psychology on discrediting psychiatric stigma","volume":"54","author":"Corrigan","year":"1999","journal-title":"Am Psychol"},{"key":"10.1016\/j.sapharm.2013.07.006_bib64","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/14659890802695840","article-title":"Experiences, attitudes and training needs of pharmacy support staff providing services to drug users in Great Britain: a qualitative study","volume":"14","author":"Mackridge","year":"2009","journal-title":"J Subst Use"},{"key":"10.1016\/j.sapharm.2013.07.006_bib65","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1046\/j.1360-0443.2002.00241.x","article-title":"Community pharmacy services for drug misusers in Scotland: what difference does 5 years make?","volume":"97","author":"Matheson","year":"2002","journal-title":"Addiction"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741113001502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741113001502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:08:10Z","timestamp":1761556090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741113001502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S1551741113001502"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2013.07.006","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contested space in the pharmacy: Public attitudes to\u00a0pharmacy harm reduction services in the West of\u00a0Scotland","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2013.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}